Black Rock Inc. Bio Atla, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Bio Atla, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,779,701 shares of BCAB stock, worth $4.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,779,701

Previous 2,884,014 3.62%

Holding current value

$4.25 Million

Previous $7.09 Million 34.79%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$1.88 - $3.46 $196,108 - $360,922	-104,313 Reduced 3.62%	2,779,701 $9.56 Million
Q4 2023 Feb 13, 2024	SELL	$1.27 - $3.18 $291,294 - $729,383	-229,366 Reduced 7.37%	2,884,014 $7.09 Million
Q3 2023 Nov 13, 2023	SELL	$1.7 - $3.07 $145,183 - $262,184	-85,402 Reduced 2.67%	3,113,380 $5.29 Million
Q2 2023 Aug 11, 2023	BUY	$2.83 - $3.87 $6.27 Million - $8.57 Million	2,215,270 Added 225.24%	3,198,782 $9.6 Million
Q1 2023 May 12, 2023	SELL	$2.3 - $8.25 $72,889 - $261,450	-31,691 Reduced 3.12%	983,512 $2.64 Million

Q4 2022 Feb 13, 2023	BUY	$7.63 - $11.01 $1.63 Million - $2.35 Million	213,556 Added 26.64%	1,015,203 $8.38 Million
Q3 2022 Nov 14, 2022	BUY	$2.94 - $11.87 $335,312 - $1.35 Million	114,052 Added 16.59%	801,647 $6.17 Million
Q2 2022 Aug 12, 2022	SELL	$2.13 - $5.38 $1.93 Million - $4.88 Million	-906,643 Reduced 56.87%	687,595 $1.96 Million
Q1 2022 May 12, 2022	BUY	$4.38 - $18.78 $36,546 - $156,700	8,344 Added 0.53%	1,594,238 $7.97 Million
Q4 2021 Feb 10, 2022	BUY	$19.0 - $30.95 $5.99 Million - $9.76 Million	315,203 Added 24.81%	1,585,894 $31.1 Million
Q3 2021 Nov 09, 2021	BUY	$29.44 - $43.74 $5.27 Million - $7.83 Million	178,914 Added 16.39%	1,270,691 $37.4 Million
Q2 2021 Aug 11, 2021	BUY	$38.07 - $56.17 $41.6 Million - $61.3 Million	1,091,777 New	1,091,777 $46.3 Million

Others Institutions Holding BCAB

# of Institutions

Shares Held

24.8M

Call Options Held

140K

Put Options Held

4.6K

View Full List

About BioAtla, Inc.

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $55.5M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

More about BCAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account